异动解读 | 创新药板块走弱,中国生物制药盘中大跌6.23%

异动解读
Sep 17

周三盘中,中国生物制药(01177)股价出现大幅下跌,截至上午10点22分左右,跌幅已达6.23%,引发市场关注。

从大盘环境来看,当日港股创新药概念股整体呈现震荡下挫态势。除中国生物制药外,维亚生物、复星医药等多只创新药概念股均出现超过4%的跌幅,君实生物、荣昌生物、信达生物等股票跌幅也超过3%。这表明中国生物制药的股价下跌可能与整个行业板块的走弱有关。

值得注意的是,尽管中国生物制药股价大幅下跌,但仍有大额交易发生。上午10:05左右,该股出现65.1万股的大手买入,成交价为8.12港元,涉资528.612万港元。截至上午10:22分左右,中国生物制药当日最高价为8.52港元,最低价为8.08港元,总成交量达8577万股,总成交金额为7.101亿港元,显示市场对该股仍存在一定的交投热度。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10